About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Mecom
MDS1 and EVI1 complex locus
MGI:95457
125 phenotypes from 9 alleles in 15 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Mecomem1(IMPC)J/Mecom+
C57BL/6NJ-Mecomem1(IMPC)J/Mmjax
thrombocytopenia J:211773
Mecomem1(IMPC)J/Mecomem1(IMPC)J
C57BL/6NJ-Mecomem1(IMPC)J/Mmjax
preweaning lethality, complete penetrance J:211773
MecomJbo/Mecom+
C3N.C-MecomJbo
abnormal craniofacial morphology J:90559
abnormal neutrophil differentiation J:113445
abnormal tympanic membrane morphology J:113445
deafness J:90559, J:113445
decreased body weight J:90559
normal immune system phenotype J:113445
increased miscarriage rate J:113445
increased susceptibility to otitis media J:113445
polydactyly J:90559, J:113445
respiratory system inflammation J:113445
tympanic membrane perforation J:113445
MecomJbo/Mecom+
involves: BALB/c
abnormal pinna reflex J:250208
normal hearing/vestibular/ear phenotype J:250208
impaired hearing J:250208
increased susceptibility to otitis media J:250208
middle ear effusion J:250208
middle ear polyps J:250208
MecomJbo/MecomJbo
C3N.C-MecomJbo
abnormal forebrain morphology J:113445
abnormal limb development J:113445
brachydactyly J:113445
distended pericardium J:113445
embryonic lethality during organogenesis, incomplete penetrance J:113445
perinatal lethality, incomplete penetrance J:113445
polydactyly J:113445
MecomJbo/Mecomtm1Mmor
involves: 129S2/SvPas * BALB/c * C3H/HeN * CF-1
perinatal lethality, complete penetrance J:113445
Mecomtm1.1Miku/Mecom+
B6.Cg-Mecomtm1.1Miku
abnormal hematopoietic stem cell morphology J:149794
abnormal platelet morphology J:149794
decreased hematopoietic stem cell number J:149794
Mecomtm1.1Miku/Mecom+
involves: C57BL/6NCrlj * CBA/JNCrlj
abnormal hematopoietic stem cell physiology J:178616
decreased hematopoietic stem cell number J:178616
Mecomtm1.1Miku/Mecomtm1.1Miku
B6.Cg-Mecomtm1.1Miku
abnormal fetal liver hematopoietic progenitor cell morphology J:149794
abnormal hematopoietic stem cell morphology J:149794
abnormal vitelline vasculature morphology J:149794
decreased hematopoietic stem cell number J:149794
hemorrhage J:149794
lethality throughout fetal growth and development, complete penetrance J:149794
pale yolk sac J:149794
skin edema J:149794
Mecomtm1Aspe/Mecomtm1Aspe
involves: 129S6/SvEvTac * C57BL/6
abnormal bone collagen fibril morphology J:207915
abnormal bone marrow cell morphology/development J:178429
abnormal common myeloid progenitor cell morphology J:178429
abnormal hematopoietic stem cell physiology J:178429
abnormal intervertebral disk morphology J:207915
abnormal ligament morphology J:207915
abnormal limb posture J:207915
abnormal lumbar vertebrae morphology J:207915
abnormal sacrum morphology J:207915
abnormal spine curvature J:207915
abnormal tail position or orientation J:207915
abnormal tendon collagen fibril morphology J:207915
abnormal vertebral articular process morphology J:207915
abnormal vertebral transverse process morphology J:207915
absent nucleus pulposus J:207915
caudal vertebral fusion J:207915
decreased body size J:178429, J:207915
decreased body weight J:207915
decreased bone mineral density J:207915
decreased bone strength J:207915
decreased bone trabecula number J:207915
decreased hematopoietic stem cell number J:178429
decreased trabecular bone connectivity density J:207915
decreased trabecular bone thickness J:207915
decreased trabecular bone volume J:207915
delayed endochondral bone ossification J:207915
exostosis J:207915
normal hematopoietic system phenotype J:178429
normal homeostasis/metabolism phenotype J:207915
increased bone trabecular spacing J:207915
increased leukocyte cell number J:178429
increased susceptibility to xenobiotic induced morbidity/mortality J:178429
intervertebral disk degeneration J:207915
kyphoscoliosis J:207915
kyphosis J:178429
lordokyphosis J:207915
lordosis J:207915
lumbar vertebral fusion J:207915
malocclusion J:178429
normal neoplasm J:178429
postnatal growth retardation J:178429, J:207915
reduced female fertility J:207915
reduced fertility J:207915
reduced male fertility J:207915
sacral vertebral fusion J:207915
normal skeleton phenotype J:207915
slow postnatal weight gain J:207915
thrombocytopenia J:178429
vertebral fusion J:207915
Mecomtm1Aspe/Mecomtm1Mmor
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6
lethality, complete penetrance J:178429
Mecomtm1Aspe/Mecomtm2.1Aspe
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129S1/SvImJ * C57BL/6 * C57BL/6J * CBA
abnormal bone marrow cell morphology/development J:178429
abnormal common myeloid progenitor cell morphology J:178429
decreased common myeloid progenitor cell number J:178429
Mecomtm1Miku/Mecom+
Tg(Tek-cre)12Flv/0
involves: C3H * C57BL/6 * CBA
decreased hematopoietic stem cell number J:149794
Mecomtm1Miku/Mecomtm1Miku
Tg(Mx1-cre)1Cgn/0
involves: C57BL/6 * CBA
abnormal hematopoietic stem cell morphology J:149794
abnormal platelet morphology J:149794
decreased hematopoietic stem cell number J:149794
thrombocytopenia J:149794
Mecomtm1Miku/Mecomtm1Miku
Tg(Tek-cre)12Flv/0
involves: C3H * C57BL/6 * CBA
decreased hematopoietic stem cell number J:149794
hemorrhage J:149794
lethality throughout fetal growth and development, incomplete penetrance J:149794
skin edema J:149794
Mecomtm1Mmor/Mecomtm1Mmor
involves: 129S2/SvPas * CF-1
abnormal amnion morphology J:42030
abnormal cranial ganglia morphology J:42030
abnormal diencephalon morphology J:42030
abnormal heart looping J:42030
abnormal liver bud morphology J:42030
abnormal mesonephros morphology J:42030
abnormal myotome development J:42030
abnormal pharyngeal arch morphology J:42030
abnormal spinal nerve morphology J:42030
abnormal superior glossopharyngeal ganglion morphology J:42030
abnormal superior vagus ganglion morphology J:42030
absent hindlimb buds J:42030
absent myotome J:42030
absent paraxial mesoderm J:42030
absent sclerotome J:42030
decreased embryo size J:42030
embryonic lethality during organogenesis, complete penetrance J:42030
enlarged pericardium J:42030
hemorrhage J:42030
incomplete somite formation J:42030
normal nervous system phenotype J:42030
pale placenta J:42030
pale yolk sac J:42030
pharyngeal arch hypoplasia J:42030
small embryonic telencephalon J:42030
small forelimb buds J:42030
small trigeminal ganglion J:42030
trabecula carnea hypoplasia J:42030
Mecomtm2.1Aspe/Mecomtm2.1Aspe
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129S1/SvImJ * C57BL/6 * CBA
abnormal bone marrow cell morphology/development J:178429
abnormal common myeloid progenitor cell morphology J:178429
decreased common myeloid progenitor cell number J:178429
Mecomtm2.2Aspe/Mecomtm2.2Aspe
involves: 129 * C57BL/6J * FVB/N
abnormal heart morphology J:213829
abnormal immune system organ morphology J:213829
decreased B cell number J:213829
decreased hematopoietic precursor cell number J:213829
decreased hematopoietic stem cell number J:213829
decreased leukocyte cell number J:213829
double outlet right ventricle J:213829
edema J:213829
hemorrhage J:213829
interrupted aortic arch J:213829
overriding aortic valve J:213829
persistent truncus arteriosus J:213829
postnatal lethality, complete penetrance J:213829
pulmonary vascular congestion J:213829
thrombocytopenia J:213829
ventricular septal defect J:213829
weakness J:213829
weight loss J:213829
Mecomtm2Miku/Mecom+
involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj
no abnormal phenotype detected J:178616

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory